|
|
|
A technique called 'RNA interference' (RNAi) holds tremendous promise as a means to cure ailments by shutting off disease-causing genes; however, it has been difficult to make the technique work in the cells that need it most. In the 11 Nov 2004 issue of Nature (Vol. 432, No. 7014, pp. 173-178), Hans-Peter Vornlocher and colleagues report a simple and ground-breaking new way to use RNAi to cut cholesterol levels in mice. The technique reveals a practical way in which RNAi might be used to treat a broad range of ailments - including coronary artery disease - that affect an animal's body.
The new work shows how RNAi could be used to treat a much broader range of diseases than is currently possible. "It remains to be seen whether [this] approach can be used to silence other disease-related genes in animal models. If so, it should revolutionise the use of RNAi", writes John Rossi in an accompanying News & Views article. INFORMATION AND CONTACT Hans-Peter Vornlocher (Alnylam Pharmaceuticals, Kulmbach, Germany)
E-mail: hpvornlocher@alnylam.de John Rossi (Beckman Research Institute of the City of Hope, Duarte, CA, USA)
Tel: +1 626 301 8360, E-mail: jrossi@coh.org (C) Nature press release.
Message posted by: Trevor M. D'Souza
|
|
Variants Associated with Pediatric Allergic Disorder
Mutations in PHF6 Found in T-Cell Leukemia
Genetic Risk Variant for Urinary Bladder Cancer
Antibody Has Therapeutic Effect on Mice with ALS
Regulating P53 Activity in Cancer Cells
Anti-RNA Therapy Counters Breast Cancer Spread
Mitochondrial DNA Diversity
The Power of RNA Sequencing
‘Pro-Ageing' Therapy for Cancer?
Niche Genetics Influence Leukaemia
Molecular Biology: Clinical Promise for RNA Interference
Chemoprevention Cocktail for Colon Cancer
more news ...
|